Viking Global Investors LP Trevi Therapeutics, Inc. Transaction History
Viking Global Investors LP
- $26.3 Billion
- Q1 2024
A detailed history of Viking Global Investors LP transactions in Trevi Therapeutics, Inc. stock. As of the latest transaction made, Viking Global Investors LP holds 4,400,000 shares of TRVI stock, worth $11.8 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
4,400,000
Previous 4,400,000
-0.0%
Holding current value
$11.8 Million
Previous $5.9 Million
157.46%
% of portfolio
0.06%
Previous 0.02%
Shares
1 transactions
Others Institutions Holding TRVI
# of Institutions
79Shares Held
50.5MCall Options Held
2.2KPut Options Held
600-
Nea Management Company, LLC Timonium, MD11.4MShares$30.5 Million2.75% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA7.38MShares$19.8 Million1.34% of portfolio
-
Rubric Capital Management LP New York, NY5.56MShares$14.9 Million0.65% of portfolio
-
Vr Adviser, LLC New York, NY3.42MShares$9.17 Million1.01% of portfolio
-
Opaleye Management Inc. Boston, MA2.65MShares$7.09 Million2.22% of portfolio
About Trevi Therapeutics, Inc.
- Ticker TRVI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,322,500
- Market Cap $156M
- Description
- Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of Haduvio to treat serious neurologically mediated conditions. The company is developing Haduvio, an oral extended-release formulation of nalbuphine, which is in phase IIb/III clinical trial for the treatment of chronic pruritu...